Thrombrophylaxis for COVID-19 Patients- Who should get what dose?


Estimated Turnout

upto 100
Based on previous editions


Mar 2021


Not Available
Claim event to edit details

This webinar will provide an update on the early results from the ACTIV-4 clinical trial studying the safety and efficacy of anti-thrombotics for .. Read more adults hospitalized with COVID-19 and competing perspectives on implementing the trial results in clinical practice. The webinar will have sessions discussing: • Interpretation of early study results by Matthew Neal, Co-chair, ACTIV-4a clinical platform and co-lead, ACTIV-4 coordinating center (20 minutes) • A conservative approach to implementation by David Jiménez (15 minutes) • Q&A moderated by Lana Castellucci (10+ minutes)

  • Share your Experience
  • Organizer

More Events From The Organizer